ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
85.90
+1.89 (2.25%)
Sep 15, 2025, 3:02 PM EDT - Market open
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $6.37 billion as of September 15, 2025. Its market cap has increased by 741.36% in one year.
Market Cap
6.37B
Enterprise Value
6.42B
1-Year Change
741.36%
Ranking
Category
Stock Price
$85.90
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $6.37B, an increase of 2,726.69%. That is a compound annual growth rate of 38.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 6.37B | 1,337.80% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | 582.13M | 95.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.33B |
| Johnson & Johnson | 427.31B |
| AbbVie | 379.28B |
| UnitedHealth Group | 316.90B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 229.97B |